Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19
2020 · ACS Central Science · 958 citations
https://doi.org/10.1021/acscentsci.0c00489
R
Richard T. Eastman
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
90
Papers
4.9K
Citations
32
h-index
56
i10-index
Richard T. Eastman is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Computational Drug Discovery Methods & Malaria Research and Control & SARS-CoV-2 and COVID-19 Research. The author has an h-index of 32, co-authored 77 publications.
ORCID: 0000-0003-3580-380XPapers by this author
works<i>Ex Vivo</i> Susceptibility of Plasmodium falciparum to Antimalarial Drugs in Western, Northern, and Eastern Cambodia, 2011-2012: Association with Molecular Markers
2013 · Antimicrobial Agents and Chemotherapy · 40 citations
https://doi.org/10.1128/aac.00687-13
A Plasmodium yoelii HECT-like E3 ubiquitin ligase regulates parasite growth and virulence
2017 · Nature Communications · 29 citations
https://doi.org/10.1038/s41467-017-00267-3
Chemoprotective antimalarials identified through quantitative high-throughput screening of Plasmodium blood and liver stage parasites
2021 · Scientific Reports · 25 citations
https://doi.org/10.1038/s41598-021-81486-z
PfCRT and PfMDR1 modulate interactions of artemisinin derivatives and ion channel blockers
2016 · Scientific Reports · 24 citations
https://doi.org/10.1038/srep25379
A Plasmodium falciparum RING Finger E3 Ubiquitin Ligase Modifies the Roles of PfMDR1 and PfCRT in Parasite Drug Responses
2023 · Antimicrobial Agents and Chemotherapy · 10 citations
https://doi.org/10.1128/aac.00821-22
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat